Science Current Events | Science News | Brightsurf.com
 

New HIV-vaccine tested on people

February 14, 2012

Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were so to say vaccinated with their own cells. The researchers filtered certain white blood cells out of the volunteer's blood, 'loaded' them outside the body and then gave them back. The immune system of the testees was better than before in attacking and suppressing the virus, the scientists reported in the top journal AIDS. But they still cannot cure the disease.

Actually, medical science can control an HIV-infection quite well, with a medicine cocktail. 'Seropositive' people (people who are infected with the HIV virus) now can lead a reasonably normal life, but their virus is not exterminated. When they stop the treatment it immediately rebounds.

Science knows what the problem is: the 'special forces' in our blood (the CD8 cells, in medical lingo) get not enough support from the general staff (the dendritic cells, that show the combat units what to attack). Dendritic cells exhibit on their exterior typical parts of the virus to be attacked. But human dendritic cells are not that good in getting the right information on the HIV virus and to transform it into good examples for the CD8 battle cells.

The virologists and HIV-physicians of the Institute of Tropical Medicine and the haematologists of Antwerp University Hospital have cooperated for years on that problem. Together they succeeded to 'load' dendritic cells of seropositive volunteers in the lab with the building instructions (genetic information in the form of so-called messenger RNA) for HIV proteins. They could make the dendritic cells to execute the instructions and to exhibit the resulting typical part of the HIV virus on their surface. Subsequent research in test tubes demonstrated that the 'loaded' dendritic cells were able to activate battle cells.

Time had come to proceed to humans. Flemish, Belgian and French research foundations provided grants. Six seropositive persons who for a long time already used the drug cocktails, were prepared to volunteer. The scientists filtered the dendritic cells from a large volume of their blood, cultivated them in test tubes in the cell-therapy unit of the Antwerp University Hospital and provided them with the genetic instructions of an HIV virus. They then froze the loaded cells.

The volunteers received four times, with four-week intervals, a small quantity of their own reworked dendritic cells. And indeed, after each vaccination the CD8 battle cells in their bodies recognised the virus better and better, while the vaccination had virtually no side effects. The most important result was that the vaccine-activated battle cells became better and better in suppressing the virus, in test tubes for the moment. But HIV remains a disguise artist; it still succeeds in changing its proteins sufficiently fast and often to let at least a few viruses escape the attack.

So it remains impossible to cure AIDS, but the results are encouraging: the vaccine, made of the participant's own dendritic cells, is safe and has some therapeutic effect, be it a limited one. But sufficiently strong for a publication in the most renowned journal for HIV researchers, AIDS. And more than sufficient to enthuse and motivate the Antwerp scientists.

Institute of Tropical Medicine Antwerp


Related HIV Vaccine Current Events and HIV Vaccine News Articles


Obesity and weight gain in HIV-infected adults on antiretroviral therapy: What's the harm?
The percentage of HIV-infected adults who were obese-body mass index >30 kg/m2-when they began antiretroviral therapy (ART) doubled over a 12-year period.

Fred Hutch endorses HPV vaccination for cancer prevention
In response to low national vaccination rates for the human papillomavirus, or HPV, Fred Hutchinson Cancer Research Center has joined with the 68 other U.S. National Cancer Institute-designated cancer centers in issuing a statement urging for increased vaccination in adolescent girls and boys for the prevention of many types of HPV-related cancers in adulthood.

In pursuit of HIV vaccine, TSRI scientists shed light on antibody origins
From Peter Parker's fateful spider bite to Arthur pulling the sword from the stone at the beginning of his reign--everyone likes to know a hero's origin story.

Have sex workers revealed a connection between semen exposure and HIV resistance?
More than half of all people infected by the HIV-1 virus worldwide are women. Commercial sex workers, who are at increased risk of contracting HIV because of repeated exposure to the virus, have long been studied to test preventive behavioral and vaccine approaches aimed at decreasing the number of infections.

Progress toward preventing HIV highlighted in special issue of AIDS research and human retroviruses
New and emerging biomedical pre-exposure prophylaxis (PrEP) approaches to prevent HIV infection in targeted high-risk populations offer the most effective near-term strategy to reduce HIV transmission.

Researchers identify a new mode of drug resistance to emerging therapies in prostate cancer
Advanced prostate cancer is a disease notoriously resistant to treatment. New research by scientists at Fred Hutchinson Cancer Research Center and the University of California, San Francisco sheds light on a new mode of drug resistance to emerging therapies in metastatic prostate cancer.

Genomic study sheds light on protective effects of malaria vaccine candidate
An international team led by researchers from the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health, and Fred Hutchinson Cancer Research Center have used cutting edge genomic methods to uncover key biological insights that help explain the protective effects of the world's most advanced malaria vaccine candidate, RTS,S/AS01 (RTS,S).

Immune responses provide clues for HIV vaccine development
Recent research has yielded new information about immune responses associated with--and potentially responsible for--protection from HIV infection, providing leads for new strategies to develop an HIV vaccine.

New study has important implications for the design of a protective HIV vaccine
A PhD student from the University of the Witwatersrand today, 12 October 2015, published a study in the prestigious journal, Nature Medicine, describing how the changing viral swarm in an HIV infected person can drive the generation of antibodies able to neutralize HIV strains from across the world.

Some vaccines support evolution of more-virulent viruses
Scientific experiments with the herpesvirus such as the one that causes Marek's disease in poultry have confirmed, for the first time, the highly controversial theory that some vaccines could allow more-virulent versions of a virus to survive, putting unvaccinated individuals at greater risk of severe illness.
More HIV Vaccine Current Events and HIV Vaccine News Articles

The River : A Journey to the Source of HIV and AIDS

The River : A Journey to the Source of HIV and AIDS
by Edward Hooper (Author)


While science has devoted much of its efforts to finding a cure for AIDS, the sources of this deadly epidemic remain largely unexamined. Distinguished science journalist Edward Hooper presents the meticulously researched -- and highly readable -- history of HIV and its possible origins. Pursuing leads across the U.S., the Caribbean, Europe, and Africa, Hooper pieces together the tantalizing clues offered by long-archived blood samples, early AIDS-like cases (such as the "Manchester sailor" case of 1959), immunodeficiency viruses (SIVs), and the medical interventions in Africa and elsewhere that may have played a role in SIVs' crossover into humans.Hooper examines over two dozen theories of origin, and eventually discards most of them. What remains is a remarkable and well-supported theory...

Vaccine Nation: America's Changing Relationship with Immunization

Vaccine Nation: America's Changing Relationship with Immunization
by Elena Conis (Author)


With employers offering free flu shots and pharmacies expanding into one-stop shops to prevent everything from shingles to tetanus, vaccines are ubiquitous in contemporary life. The past fifty years have witnessed an enormous upsurge in vaccines and immunization in the United States: American children now receive more vaccines than any previous generation, and laws requiring their immunization against a litany of diseases are standard. Yet, while vaccination rates have soared and cases of preventable infections have plummeted, an increasingly vocal cross section of Americans have questioned the safety and necessity of vaccines. In Vaccine Nation, Elena Conis explores this complicated history and its consequences for personal and public health.

Vaccine Nation opens in the 1960s,...

HIV Essentials 2014

HIV Essentials 2014
by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author)


The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. Completely revised and updated, HIV Essentials 2014 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.

Immunology and the Quest for an HIV Vaccine: A New Perspective

Immunology and the Quest for an HIV Vaccine: A New Perspective
by Dr. Omar Bagasra (Author)


How many human immune systems are there? How old are they? Why is there no AIDS vaccine? Is a new approach needed? Why is public opinion growing skeptical of the scientific community after three decades of public awareness about HIV/AIDS? Consider answers to these puzzling questions. Learn from the decades of experience of two senior scholars: Dr. Omar Bagasra (an eminent molecular biologist, immunologist, and retrovirologist) and Dr. Donald Gene Pace (a highly published writer who examines public health policy). Explore intriguing new possibilities about human immunity, and the development of an effective AIDS vaccine. Read Immunology and the Quest for an HIV Vaccine. Benefit from an informed synthesis backed by a wealth of peer-reviewed scientific references. Review basic concepts of...

Advances in HIV-1 Vaccine Volume I

Advances in HIV-1 Vaccine Volume I
by Christian Brander (Author), Dan H Barouch (Author), George Dickson (Author), Lucy Dorrell (Author), Ronald E Bontrop (Author)


Since the human immunodeficiency virus (HIV) was identified as the causative agent of acquired immunodeficiency syndrome (AIDS), the Human Immunodeficiency Virus (HIV) represents a worldwide threat to public health and the economy. It has been estimated that 35.3 (32.2-38.8) million people were living with HIV globally at the end of 2012. HIV has two major types, HIV-1 and HIV-2, which are further divided into groups, subtypes and recombinant forms. Globally, over 90% of HIV infections belong to HIV-1 group M viruses. Despite of the successful use of highly active antiretroviral therapy, the high genetic diversity of the HIV genomehas challenged the development of drugs and vaccines. Twenty-five years of research into development of a vaccine to prevent or control HIV-1 infection doesn't...

Advances in HIV-1 Vaccine Volume II

Advances in HIV-1 Vaccine Volume II
by Christian Brander (Author), Dan H Barouch (Author), George Dickson (Author), Lucy Dorrell (Author), Ronald E Bontrop (Author)


Since the human immunodeficiency virus (HIV) was identified as the causative agent of acquired immunodeficiency syndrome (AIDS), the Human Immunodeficiency Virus (HIV) represents a worldwide threat to public health and the economy.It has been estimated that 35.3 (32.2-38.8) million people were living with HIV globally at the end of 2012. HIV has two major types, HIV-1 and HIV-2, which are further divided into groups, subtypes and recombinant forms. Globally, over 90% of HIV infections belong to HIV-1 group M viruses. Despite of the successful use of highly active antiretroviral therapy, the high genetic diversity of the HIV genomehas challenged the development of drugs and vaccines. Twenty-five years of research into development of a vaccine to prevent or control HIV-1 infection doesn't...

The Cure for HIV And AIDS

The Cure for HIV And AIDS
by Hulda Regehr Clark (Author)


A work on the cure for HIV and AIDS. It helps to recover near terminal victims.

Immunology and the Quest for an HIV Vaccine: A New Perspective

Immunology and the Quest for an HIV Vaccine: A New Perspective
by AuthorHouse


"How many human immune systems are there? How old are they? Why is there no AIDS vaccine? Is a new approach needed? Why is public opinion growing skeptical of the scientific community after three decades of public awareness about HIV/AIDS?

Consider answers to these puzzling questions. Learn from the decades of experience of two senior scholars: Dr. Omar Bagasra (an eminent molecular biologist, immunologist, and retrovirologist) and Dr. Donald Gene Pace (a highly published writer who examines public health policy). Explore intriguing new possibilities about human immunity, and the development of an effective AIDS vaccine.

Read Immunology and the Quest for an HIV Vaccine. Benefit from an informed synthesis backed by a wealth of peer-reviewed scientific references....

The Effectiveness of a Vaccine for HIV: How Close Are We to the End of the Epidemic?

The Effectiveness of a Vaccine for HIV: How Close Are We to the End of the Epidemic?
by Michael A. Capristo (Author)


This work examines the HIV and AIDS pandemic; its history, research into likely genetic lineage, mutations and species crossover. This work included review of recent literature, studies and clinical research which were aimed at understanding HIV/AIDS in order to develop methods of infection prevention including; education, vaccine and genetic modification strategies. Increasing numbers of studies, trials and clinical research have been gaining recognition and provided insightful knowledge of groundbreaking approaches to fighting HIV and AIDS. To explore how the combination of recent research breakthroughs might affect the fight against the pandemic going forward, this thesis analyzed numerous literature sources and studies.

HIV and the Pathogenesis of AIDS, 3rd Edition

HIV and the Pathogenesis of AIDS, 3rd Edition
by Jay A. Levy (Author)


A state-of-the-art review of the current research.
• Explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition.
• Explores potential approaches for therapy, including a vaccine for the prevention of HIV infection and AIDS.
• Serves as a valuable reference for students, researchers, clinicians, and health care providers.

© 2016 BrightSurf.com